⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetonitrile SCHEMBL11848905 | 1.00 | TTR (0.50) | — | |
| Dioxane SCHEMBL2549097 | 1.00 | TTR (0.50) | — | |
| Oxirane SCHEMBL6008970 | 0.96 | — | — | |
| Dioxane SCHEMBL5129205 | 0.87 | TTR (0.38) | — | |
| Acetonitrile SCHEMBL2815212 | 0.85 | — | — | |
| Tetrahydrofuran SCHEMBL20135739 | 0.85 | ALDH1A1 (0.57) | — | |
| Tetrahydrofuran SCHEMBL1041391 | 0.85 | — | — | |
| Tetrahydrofuran SCHEMBL509785 | 0.85 | — | — | |
| Tetrahydrofuran SCHEMBL29033463 | 0.85 | ALDH1A1 (0.57) | — | |
| Acetonitrile SCHEMBL35968 | 0.82 | ALDH1A1 (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117903192-A | Preparation method of 3-methoxy isoquinoline compound intermediate | 上海相辉医药科技有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-113788777-B | Method for preparing 1-substituted-3-carbonyl pyrrole | 华中科技大学 | 2023-04-11 | — | — | CN | claimed |
| CN-113788777-A | Method for preparing 1-substituted-3-carbonyl pyrrole | 华中科技大学 | 2021-12-14 | — | — | CN | claimed |
| EP-3784676-A1 | POLYMORPHIC FORMS OF BICTEGRAVIR AND ITS SODIUM SALT | Mylan Laboratories Ltd. (IN) | 2021-03-03 | — | — | EP | claimed |
| US-20140238293-A1 | Crimping Apparatus | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2014-08-28 | — | — | US | claimed |
| US-8739379-B2 | Crimping apparatus | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2014-06-03 | — | — | US | claimed |
| US-20110283501-A1 | CRIMPING APPARATUS | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2011-11-24 | — | — | US | claimed |
| US-8015687-B2 | Method of inserting self-expandable stent in a sheath | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2011-09-13 | — | — | US | claimed |
| US-8011078-B2 | Method of producing stent-balloon assembly | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2011-09-06 | — | — | US | claimed |
| JP-4733109-B2 | — | — | 2011-07-27 | — | — | JP | claimed |
| US-20100192353-A1 | Method of Producing Stent-Balloon Assembly | PACETTI STEPHEN DIRK | 2010-08-05 | — | — | US | claimed |
| US-20100115755-A1 | Method of Inserting Self-Expandable Stent in a Sheath | PACETTI STEPHEN DIRK | 2010-05-13 | — | — | US | claimed |
| JP-2008500967-A | — | — | 2008-01-17 | — | — | JP | claimed |
| US-7235676-B2 | Catalytic process for the preparation of epoxides from alkenes | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2007-06-26 | — | — | US | claimed |
| EP-1732910-A1 | AN IMPROVED CATALYTIC PROCESS FOR THE PREPARATION OF EPOXIDES FROM ALKENES | Council of Scientific and Industrial Research (IN) | 2006-12-20 | — | — | EP | claimed |
| WO-2005095370-A1 | AN IMPROVED CATALYTIC PROCESS FOR THE PREPARATION OF EPOXIDES FROM ALKENES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2005-10-13 | — | — | WO | claimed |
| US-20050222440-A1 | Catalytic process for the preparation of epoxides from alkenes | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2005-10-06 | — | — | US | claimed |
| CN-1093370-A | A kind of new azido erythromycin crystal and preparation method thereof | JICAI MEDICINE RESEARCH INST B (CN) | 1994-10-12 | — | — | CN | claimed |
| EP-0005524-A1 | Omega-(1,3-dithiolan-2-imino)substituted acetic acids, process for their preparation and pharmaceutical compositions containing them | MERRELL DOW PHARMACEUTICALS, INC. (US) | 1979-11-28 | — | — | EP | claimed |
| CN-117447481-A | Amorphous substance of Martinib-pyroglutamate and preparation method and application thereof | 潍坊医学院 | 2024-01-26 | — | — | CN | disclosed |
| US-20240018121-A1 | NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE | FOX CHASE CHEMCIAL DIVERSITY CENTER, INC. (US) | 2024-01-18 | — | — | US | disclosed |
| US-11691967-B2 | Antibiotics effective for gram-negative pathogens | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2023-07-04 | — | — | US | disclosed |
| CN-113788777-B | Method for preparing 1-substituted-3-carbonyl pyrrole | 华中科技大学 | 2023-04-11 | — | — | CN | disclosed |
| CN-115521223-A | Method for recycling unsymmetrical dimethylhydrazine waste liquid | 西安航洁化工科技有限责任公司 | 2022-12-27 | — | — | CN | disclosed |
| EP-4058455-A1 | NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE | Temple University - Of The Commonwealth System of Higher Education (US) | 2022-09-21 | — | — | EP | disclosed |
| EP-4028130-A1 | BENZYL AMINE-CONTAINING 5,6-HETEROAROMATIC COMPOUNDS USEFUL AGAINST MYCOBACTERIAL INFECTION | Shionogi & Co., Ltd (JP) | 2022-07-20 | — | — | EP | disclosed |
| CN-113788777-A | Method for preparing 1-substituted-3-carbonyl pyrrole | 华中科技大学 | 2021-12-14 | — | — | CN | disclosed |
| US-20210355137-A1 | POLYMORPHIC FORMS OF BICTEGRAVIR AND ITS SODIUM SALT | MYLAN LABORATORIES LIMITED (IN) | 2021-11-18 | — | — | US | disclosed |
| WO-2021097116-A1 | NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2021-05-20 | — | — | WO | disclosed |
| CN-109970714-B | Tetradentate platinum (II) complex and application thereof | 广东阿格蕾雅光电材料有限公司 | 2021-04-13 | — | — | CN | disclosed |
| WO-2021050708-A1 | BENZYL AMINE-CONTAINING 5,6-HETEROAROMATIC COMPOUNDS USEFUL AGAINST MYCOBACTERIAL INFECTION | SHIONOGI & CO., LTD. (JP) | 2021-03-18 | — | — | WO | disclosed |
| EP-3784676-A1 | POLYMORPHIC FORMS OF BICTEGRAVIR AND ITS SODIUM SALT | Mylan Laboratories Ltd. (IN) | 2021-03-03 | — | — | EP | disclosed |
| CN-109980111-B | Organic electroluminescent device containing tetradentate platinum (II) complex | 广东阿格蕾雅光电材料有限公司 | 2021-02-19 | — | — | CN | disclosed |
| US-20210017165-A1 | ANTIBIOTICS EFFECTIVE FOR GRAM-NEGATIVE PATHOGENS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2021-01-21 | — | — | US | disclosed |
| US-20200369665-A1 | IMIDAZO[1,2-A]PYRAZINE MODULATORS OF THE ADENOSINE A2A RECEPTOR | Ryvu Therapeutics S.A. (PL) | 2020-11-26 | — | — | US | disclosed |
| CN-111735781-A | Triphenylamine grafted ruthenium complex ratio luminescence pH sensor | 北京师范大学 | 2020-10-02 | — | — | CN | disclosed |
| CN-108088929-B | Analysis method of L-phenylglycine ethyl dane potassium salt | 天津大学 | 2020-05-29 | — | — | CN | disclosed |
| CN-108350307-B | The manufacturing method of metal surface treating composition, metal material | 日本帕卡濑精株式会社 | 2019-11-05 | — | — | CN | disclosed |
| CN-110325518-A | Thiazolium compounds and herbicide | 日本欧爱特农业科技株式会社 | 2019-10-11 | — | — | CN | disclosed |
| US-20190142798-A1 | POLYMER-DES-ETHYL SUNITINIB CONJUGATES | NEKTAR THERAPEUTICS | 2019-05-16 | — | — | US | disclosed |
| EP-3283481-B1 | CHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS | CHIESI FARM SPA (IT) | 2019-03-13 | — | — | EP | disclosed |
| US-10220020-B2 | Polymer-des-ethyl sunitinib conjugates | NEKTAR THERAPEUTICS (US) | 2019-03-05 | — | — | US | disclosed |
| CN-105001114-B | Prepare the new method of Iopromide | 沈阳中海生物技术开发有限公司 | 2018-11-20 | — | — | CN | disclosed |
| CN-105017063-B | 5- amino -2,4,6- triiodo isophthalic acid derivatives and its salt, hydrate or solvate | 沈阳中海生物技术开发有限公司 | 2018-11-20 | — | — | CN | disclosed |
| CN-108350307-A | The manufacturing method of metal surface treating composition, metal material | 日本帕卡濑精株式会社 | 2018-07-31 | — | — | CN | disclosed |
| CN-108088929-A | A kind of analysis method of L-Phenylglycine ethyl dane potassium salts | 华北制药股份有限公司 | 2018-05-29 | — | — | CN | disclosed |
| US-9968604-B2 | Chromene derivatives as phoshoinositide 3-kinases inhibitors | CHIESI FARMACEUTICI S.P.A. (IT) | 2018-05-15 | — | — | US | disclosed |
| US-9949854-B2 | Crimping method | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2018-04-24 | — | — | US | disclosed |
| CN-104781288-B | Process for producing terminal-modified polybutadiene or terminal-modified hydrogenated polybutadiene, and composition containing same | 日本曹达株式会社 | 2018-04-20 | — | — | CN | disclosed |
| EP-3283481-A1 | CHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS | Chiesi Farmaceutici S.p.A. (IT) | 2018-02-21 | — | — | EP | disclosed |
| CN-107501542-A | A kind of preparation method of Amino End Group polyethylene glycol t-butyl carbamate | 湖南华腾制药有限公司 | 2017-12-22 | — | — | CN | disclosed |
| CN-104093737-B | Antibodies specific for trans-resveratrol and uses thereof | IP科技有限公司 | 2017-11-21 | — | — | CN | disclosed |
| US-20170326148-A1 | PREVENTION OR TREATMENT OF URIC ACID OR GOUT DISEASE | Shanton Pharma Pte. Ltd. (SG) | 2017-11-16 | — | — | US | disclosed |
| EP-2654797-B1 | POLYMER-DES-ETHYL SUNITINIB CONJUGATES | NEKTAR THERAPEUTICS (US) | 2017-11-08 | — | — | EP | disclosed |
| WO-2017171239-A1 | ION EXCHANGE SEPARATION MEMBRANE, ELECTROCHEMICAL CELL INCLUDING SAME, FLOW CELL AND FUEL CELL, AND MANUFACTURING METHOD THEREOF | 주식회사 엘지화학 | 2017-10-05 | — | — | WO | disclosed |
| US-20170252191-A1 | CRIMPING METHOD | ABBOTT CARDIOVASCULAR SYSTEMS INC (US) | 2017-09-07 | — | — | US | disclosed |
| US-20170202839-A1 | Crystalline Form of Pemirolast | RSPR PHARMA AB (SE) | 2017-07-20 | — | — | US | disclosed |
| US-9675484-B2 | Crimping method | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2017-06-13 | — | — | US | disclosed |
| US-20170146524-A1 | ANTIBODY SPECIFIC FOR TRANS-RESVERATROL AND USE THEREOF | IP SCIENCE LIMITED (GB) | 2017-05-25 | — | — | US | disclosed |
| EP-3141549-A1 | CRYSTALLINE FORM OF PEMIROLAST FOR USE IN THE TREATMENT OF INFLAMMATIONS | RSPR Pharma AB (SE) | 2017-03-15 | — | — | EP | disclosed |
| CN-105102415-B | Method for improving optical purity of 2-hydroxycarboxylic acid or derivative thereof | 兴和株式会社 | 2017-03-15 | — | — | CN | disclosed |
| US-9547001-B2 | Antibody specific for trans-resveratrol and use thereof | IP SCIENCE LIMITED (GB) | 2017-01-17 | — | — | US | disclosed |
| CN-106317099-A | Aminoalkylalkoxydisiloxane compound and method for preparing the same | 信越化学工业株式会社 | 2017-01-11 | — | — | CN | disclosed |
| EP-2443120-B1 | CRYSTALLINE FORM OF PEMIROLAST | RSPR PHARMA AB (SE) | 2016-11-02 | — | — | EP | disclosed |
| US-20160303123-A1 | CHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2016-10-20 | — | — | US | disclosed |
| WO-2016166239-A1 | CHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2016-10-20 | — | — | WO | disclosed |
| US-20160278956-A1 | CRIMPING METHOD | ABBOTT CARDIOVASCULAR SYSTEMS INC (US) | 2016-09-29 | — | — | US | disclosed |
| EP-2776464-B1 | ANTIBODY SPECIFIC FOR TRANS-RESVERATROL AND USE THEREOF | IP SCIENCE LTD (GB) | 2016-09-28 | — | — | EP | disclosed |
| US-20160250217-A1 | CRYSTALLINE FORM OF PEMIROLAST | RSPR PHARMA AB (SE) | 2016-09-01 | — | — | US | disclosed |
| US-9388172-B2 | Substituted carbamate compounds | HOFFMANN-LA ROCHE INC. (US) | 2016-07-12 | — | — | US | disclosed |
| CN-103717593-B | Regulate kinase whose compositions and method | 克勒韦谢尔制药公司 | 2016-07-06 | — | — | CN | disclosed |
| CN-105732635-A | Toll-like receptor 7 agonist | 南京明德新药研发股份有限公司 | 2016-07-06 | — | — | CN | disclosed |
| US-9375334-B2 | Crimping method | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2016-06-28 | — | — | US | disclosed |
| EP-2718290-B1 | COMPOSITIONS AND METHODS FOR MODULATING A KINASE | CLEVEXEL PHARMA (FR) | 2016-05-04 | — | — | EP | disclosed |
| CN-105017063-A | 5-amino-2,4,6-triiodo m-phthalic acid derivative and salt, hydrate or solvate | J&HEALTH BIOTECHNOLOGY CO LTD | 2015-11-04 | — | — | CN | disclosed |
| CN-105001114-A | New method for preparing iopromide | J&HEALTH BIOTECHNOLOGY CO LTD | 2015-10-28 | — | — | CN | disclosed |
| US-20150282969-A1 | Crimping Method | ABBOTT CARDIOVASCULAR SYSTEMS (US) | 2015-10-08 | — | — | US | disclosed |
| EP-2917208-A1 | [3-HETEROARYL-2-TRIFLUOROMETHYL-PROPYL]-PIPERIDIN-1-YLE OR -MORPHOLIN-4-YLE COMPOUNDS AS TRPA1 ANTAGONISTS FOR THE TREATMENT OF RESPIRATORY DISEASES | F. Hoffmann-La Roche AG (CH) | 2015-09-16 | — | — | EP | disclosed |
| US-20150239873-A1 | SUBSTITUTED CARBAMATE COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 2015-08-27 | — | — | US | disclosed |
| WO-2015082592-A2 | METHOD FOR PREPARING AMINOARYLBORANE COMPOUNDS OR DERIVATIVES THEREOF | Universite de Bordeaux (FR) | 2015-06-11 | — | — | WO | disclosed |
| EP-2881398-A1 | Method for preparing aminoarylborane compounds or derivatives thereof | Université de Bordeaux I (FR) | 2015-06-10 | — | — | EP | disclosed |
| US-9044312-B2 | Crimping method | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2015-06-02 | — | — | US | disclosed |
| US-9006431-B2 | Crystalline form of pemirolast | RSPR PHARMA AB (SE) | 2015-04-14 | — | — | US | disclosed |
| US-8937065-B2 | Compositions and methods for modulating a kinase | CLEVEXEL PHARMA (FR) | 2015-01-20 | — | — | US | disclosed |
| US-20140349319-A1 | ANTIBODY SPECIFIC FOR TRANS-RESVERATROL AND USE THEREOF | IP SCIENCE LIMITED (GB) | 2014-11-27 | — | — | US | disclosed |
| US-20140329839-A1 | New Crystalline Form of Pemirolast | CARDOZ AB (SE) | 2014-11-06 | — | — | US | disclosed |
| CN-104093737-A | Antibodies specific for trans-resveratrol and uses thereof | IP SCIENCE LTD | 2014-10-08 | — | — | CN | disclosed |
| EP-2776464-A1 | ANTIBODY SPECIFIC FOR TRANS - RESVERATROL AND USE THEREOF | IP Science Limited (GB) | 2014-09-17 | — | — | EP | disclosed |
| US-20140238293-A1 | Crimping Apparatus | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2014-08-28 | — | — | US | disclosed |
| EP-2768810-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | Calcimedica, Inc. (US) | 2014-08-27 | — | — | EP | disclosed |
| US-8739379-B2 | Crimping apparatus | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2014-06-03 | — | — | US | disclosed |
| EP-2079845-B1 | Process for producing vessels containing bacterial cellulose | ARTERION AB (SE) | 2014-05-21 | — | — | EP | disclosed |
| WO-2014072325-A1 | [3-HETEROARYL-2-TRIFLUOROMETHYL-PROPYL]-PIPERIDIN-1-YLE OR -MORPHOLIN-4-YLE COMPOUNDS AS TRPA1 ANTAGONISTS FOR THE TREATMENT OF RESPIRATORY DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 2014-05-15 | — | — | WO | disclosed |
| EP-2718290-A2 | COMPOSITIONS AND METHODS FOR MODULATING A KINASE | Clevexel Pharma (FR) | 2014-04-16 | — | — | EP | disclosed |
| US-20140039030-A1 | POLYMER-DES-ETHYL SUNITINIB CONJUGATES | NEKTAR THERAPEUTICS (US) | 2014-02-06 | — | — | US | disclosed |
| EP-2654797-A1 | POLYMER-DES-ETHYL SUNITINIB CONJUGATES | Nektar Therapeutics (US) | 2013-10-30 | — | — | EP | disclosed |
| WO-2013136296-A2 | WATER-SOLUBLE ORGANOMETALLIC RUTHENIUM AND IRON COMPUNDS PRESENTING HETEROAROMATIC LIGANDS | UNIVERSIDADE DE LISBOA (PT) | 2013-09-19 | — | — | WO | disclosed |
| WO-2013068758-A1 | ANTIBODY SPECIFIC FOR TRANS - RESVERATROL AND USE THEREOF | IP SCIENCE LIMITED (GB) | 2013-05-16 | — | — | WO | disclosed |
| WO-2013059666-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | CALCIMEDICA, INC. (US) | 2013-04-25 | — | — | WO | disclosed |
| WO-2012172438-A9 | COMPOSITIONS AND METHODS FOR MODULATING A KINASE | DYNAMIX PHARMACEUTICALS LTD. (IL) | 2013-02-07 | — | — | WO | disclosed |
| WO-2012172438-A2 | COMPOSITIONS AND METHODS FOR MODULATING A KINASE | DYNAMIX PHARMACEUTICALS LTD. (IL) | 2012-12-20 | — | — | WO | disclosed |
| US-20120316148-A1 | Compositions and Methods for Modulating a Kinase | DYNAMIX PHARMACEUTICALS LTD. (IL) | 2012-12-13 | — | — | US | disclosed |
| US-8273706-B2 | Isobarically labeled analytes and fragment ions derived therefrom | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2012-09-25 | — | — | US | disclosed |
| US-20120220558-A1 | Methods of Treating Hormone-Related Conditions Using Thio-Oxindole Derivatives | WYETH LLC (US) | 2012-08-30 | — | — | US | disclosed |
| US-8242098-B2 | Methods of treating hormone-related conditions using thio-oxindole derivatives | WYETH LLC (US) | 2012-08-14 | — | — | US | disclosed |
| WO-2012088522-A1 | POLYMER-DES-ETHYL SUNITINIB CONJUGATES | NEKTAR THERAPEUTICS (US) | 2012-06-28 | — | — | WO | disclosed |
| US-20120157415-A1 | New Crystalline Form of Pemirolast | CARDOZ AB (SE) | 2012-06-21 | — | — | US | disclosed |
| WO-2010146348-A9 | CRYSTALLINE FORM OF PEMIROLAST | CARDOZ AB (SE) | 2012-05-03 | — | — | WO | disclosed |
| EP-2443120-A2 | NEW CRYSTALLINE FORM OF PEMIROLAST | Cardoz AB (SE) | 2012-04-25 | — | — | EP | disclosed |
| EP-2426211-A1 | Bacterial cellulose tubes | Arterion AB (SE) | 2012-03-07 | — | — | EP | disclosed |
| US-20110283501-A1 | CRIMPING APPARATUS | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2011-11-24 | — | — | US | disclosed |
| US-8020273-B2 | High humidity crimping process | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2011-09-20 | — | — | US | disclosed |
| US-8015684-B2 | Crimping apparatus | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2011-09-13 | — | — | US | disclosed |
| US-8015687-B2 | Method of inserting self-expandable stent in a sheath | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2011-09-13 | — | — | US | disclosed |
| US-8011078-B2 | Method of producing stent-balloon assembly | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2011-09-06 | — | — | US | disclosed |
| EP-1405922-B1 | Substrates for beta-lactamase and uses thereof | UNIV CALIFORNIA (US) | 2011-08-24 | — | — | EP | disclosed |
| WO-2010146348-A2 | NEW CRYSTALLINE FORM OF PEMIROLAST | CARDOZ AB (SE) | 2010-12-23 | — | — | WO | disclosed |
| WO-2010146341-A2 | NEW CRYSTALLINE FORM OF PEMIROLAST | CARDOZ AB (SE) | 2010-12-23 | — | — | WO | disclosed |
| EP-2251334-A1 | Labeling reagents and labeled analytes | Life Technologies Corporation (US) | 2010-11-17 | — | — | EP | disclosed |
| EP-2229397-A2 | PROCESS FOR PREPARING RISEDRONATE SODIUM AS ANHYDROUS AND HYDRATE FORMS | Dongwoo Syntech Co., Ltd. (KR) | 2010-09-22 | — | — | EP | disclosed |
| EP-1701945-B1 | LABELING REAGENTS, LABELED ANALYTES, INCLUDING MIXTURES THEREOF, AND FRAGMENT IONS DERIVED THEREFROM AND METHODS FOR THE ANALYSIS THEREOF | LIFE TECHNOLOGIES CORP (US) | 2010-09-01 | — | — | EP | disclosed |
| US-20100192353-A1 | Method of Producing Stent-Balloon Assembly | PACETTI STEPHEN DIRK | 2010-08-05 | — | — | US | disclosed |
| US-20100129842-A1 | ISOBARICALLY LABELED ANALYTES AND FRAGMENT IONS DERIVED THEREFROM | Life Technologies Corporation (US) | 2010-05-27 | — | — | US | disclosed |
| US-20100122446-A1 | Crimping Apparatus | PACETTI STEPHEN DIRK | 2010-05-20 | — | — | US | disclosed |
| US-20100115759-A1 | High Humidity Crimping Process | PACETTI STEPHEN DIRK | 2010-05-13 | — | — | US | disclosed |
| US-20100115755-A1 | Method of Inserting Self-Expandable Stent in a Sheath | PACETTI STEPHEN DIRK | 2010-05-13 | — | — | US | disclosed |
| US-7673379-B1 | providing a stent having a polymeric component, wherein the polymeric component is a phosphoryl choline acrylate polymer, exposing the stent to a relative humidity of 20% to 100%, and crimping the stent on a balloon of a catheter assembly | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2010-03-09 | — | — | US | disclosed |
| US-20100042197-A1 | PREPARATION OF HOLLOW CELLULOSE VESSELS | ARTERION AB (SE) | 2010-02-18 | — | — | US | disclosed |
| EP-2079845-A2 | ARTIFICIAL VESSELS | Arterion AB (SE) | 2009-07-22 | — | — | EP | disclosed |
| WO-2009072769-A2 | PROCESS FOR PREPARING RISEDRONATE SODIUM AS ANHYDROUS AND HYDRATE FORMS | DONGWOO SYNTECH CO., LTD (KR) | 2009-06-11 | — | — | WO | disclosed |
| US-20090099223-A1 | METHODS OF TREATING HORMONE-RELATED CONDITIONS USING THIO-OXINDOLE DERIVATIVES | WYETH (US) | 2009-04-16 | — | — | US | disclosed |
| US-7488734-B2 | Methods of treating hormone-related conditions using thio-oxindole derivatives | WYETH (US) | 2009-02-10 | — | — | US | disclosed |
| EP-1077686-B1 | EXTERNALLY TRIGGERED MICROCAPSULES | NASA JOHNSON SPACE CT (US) | 2008-08-06 | — | — | EP | disclosed |
| WO-2008040729-A2 | PROCESS FOR THE PREPARATION OF HOLLOW CELLULOSE VESSELS BY CULTURING CELLULOSE- PRODUCING MICROORGANISMS ON THE SURFACE OF A HOLLOW CARRIER AND PROVIDING A GAS HAVING AN OXYGEN LEVEL OF AT LEAST 35% | ARTERION AB (SE) | 2008-04-10 | — | — | WO | disclosed |
| US-7235676-B2 | Catalytic process for the preparation of epoxides from alkenes | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2007-06-26 | — | — | US | disclosed |
| EP-1732910-A1 | AN IMPROVED CATALYTIC PROCESS FOR THE PREPARATION OF EPOXIDES FROM ALKENES | Council of Scientific and Industrial Research (IN) | 2006-12-20 | — | — | EP | disclosed |
| US-7115649-B2 | Methods of treating skin disorders using thio-oxindole derivatives | WYETH (US) | 2006-10-03 | — | — | US | disclosed |
| EP-1701945-A1 | LABELING REAGENTS, LABELED ANALYTES, INCLUDING MIXTURES THEREOF, AND FRAGMENT IONS DERIVED THEREFROM AND METHODS FOR THE ANALYSIS THEREOF | Applera Corporation (US) | 2006-09-20 | — | — | EP | disclosed |
| US-7091234-B2 | Thio-oxindole derivatives | WYETH (US) | 2006-08-15 | — | — | US | disclosed |
| WO-2005095370-A1 | AN IMPROVED CATALYTIC PROCESS FOR THE PREPARATION OF EPOXIDES FROM ALKENES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2005-10-13 | — | — | WO | disclosed |
| US-20050222440-A1 | Catalytic process for the preparation of epoxides from alkenes | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2005-10-06 | — | — | US | disclosed |
| EP-1531806-A4 | USE OF THIO-OXINDOLE DERIVATIVES IN TREATMENT OF HORMONE-RELATED CONDITIONS | WYETH CORP (US) | 2005-09-21 | — | — | EP | disclosed |
| EP-1515680-A4 | USE OF THIO-OXINDOLE DERIVATIVES IN TREATMENT OF SKIN DISORDERS | WYETH CORP (US) | 2005-09-21 | — | — | EP | disclosed |
| US-6946454-B2 | Thio-oxindole derivatives | WYETH (US) | 2005-09-20 | — | — | US | disclosed |
| CN-1662206-A | Use of thio-2-oxindole derivatives in treatment of skin disorders | WYETH CORP (US) | 2005-08-31 | — | — | CN | disclosed |
| US-20050171186-A1 | 3-(1',2'-Dihydro-2'-thioxospiro[cyclohexane-1,3'-[3H]indol]-5'-yl)benzonitrile; 5'-(5-Cyano-1-methyl-1H-pyrrol-2-yl)spiro[cyclohexane-1,3'-[3H]indol]-2'-ylidenecyanamide; progesterone receptor agonist; mixture with estrone (estrogen); hormone replacement therapy, contraception; anticarcinogenic | WYETH (US) | 2005-08-04 | — | — | US | disclosed |
| WO-2005068446-A1 | LABELING REAGENTS, LABELED ANALYTES, INCLUDING MIXTURES THEREOF, AND FRAGMENT IONS DERIVED THEREFROM AND METHODS FOR THE ANALYSIS THEREOF | APPLERA CORPORATION (US) | 2005-07-28 | — | — | WO | disclosed |
| US-20050148087-A1 | Isobarically labeled analytes and fragment ions derived therefrom | APPLERA CORPORATION | 2005-07-07 | — | — | US | disclosed |
| US-20050147985-A1 | Mixtures of isobarically labeled analytes and fragments ions derived therefrom | APPLERA CORPORATION | 2005-07-07 | — | — | US | disclosed |
| EP-1531806-A2 | USE OF THIO-OXINDOLE DERIVATIVES IN TREATMENT OF HORMONE-RELATED CONDITIONS | Wyeth (US) | 2005-05-25 | — | — | EP | disclosed |
| US-6875765-B2 | Arylsulfonamide ethers, and methods of use thereof | WARNER-LAMBERT COMPANY (US) | 2005-04-05 | — | — | US | disclosed |
| EP-1515680-A2 | USE OF THIO-OXINDOLE DERIVATIVES IN TREATMENT OF SKIN DISORDERS | Wyeth (US) | 2005-03-23 | — | — | EP | disclosed |
| US-20050054711-A1 | Thio-oxindole derivatives | WYETH | 2005-03-10 | — | — | US | disclosed |
| US-6841568-B2 | Thio-oxindole derivatives | WYETH (US) | 2005-01-11 | — | — | US | disclosed |
| US-20040006122-A1 | Methods of treating skin disorders using thio-oxindole derivatives | WYETH | 2004-01-08 | — | — | US | disclosed |
| US-20040002535-A1 | Methods of treating hormone-related conditions using thio-oxindole derivatives | WYETH (US) | 2004-01-01 | — | — | US | disclosed |
| WO-2004000225-A2 | USE OF THIO-OXINDOLE DERIVATIVES IN TREATMENT OF HORMONE-RELATED CONDITIONS | WYETH (US) | 2003-12-31 | — | — | WO | disclosed |
| WO-2004000227-A2 | USE OF THIO-OXINDOLE DERIVATIVES IN TREATMENT OF SKIN DISORDERS | WYETH (US) | 2003-12-31 | — | — | WO | disclosed |
| US-20030225109-A1 | Thio-oxindole derivatives | WYETH (US) | 2003-12-04 | — | — | US | disclosed |
| US-6583145-B1 | Thio-oxindole derivatives | WYETH | 2003-06-24 | — | — | US | disclosed |
| US-20030096826-A1 | Arylsulfonamide ethers, and methods of use thereof | WARNER-LAMBERT COMPANY | 2003-05-22 | — | — | US | disclosed |
| US-20030064978-A1 | Novel compounds | ASTRAZENECA AB. (SE) | 2003-04-03 | — | — | US | disclosed |
| US-6521657-B2 | Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal | WYETH | 2003-02-18 | — | — | US | disclosed |
| US-20020169198-A1 | Thio-oxindole derivatives | WYETH (US) | 2002-11-14 | — | — | US | disclosed |
| US-20020103248-A1 | Thio-oxindole derivatives | WYETH LLC | 2002-08-01 | — | — | US | disclosed |
| WO-2002028808-A1 | TRIPTYCENE ANALOGS | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2002-04-11 | — | — | WO | disclosed |
| US-6355648-B1 | COMPOUNDS AS CONTRACEPTIVES AND PROGESTERONE ANTAGONIST | AMERICAN HOME PRODUCTS CORPORATION | 2002-03-12 | — | — | US | disclosed |
| EP-1181275-A1 | THIO-OXINDOLE DERIVATIVES | American Home Products Corporation (US) | 2002-02-27 | — | — | EP | disclosed |
| US-6297231-B1 | CARBOXYLATION OF NITROGEN IN PYRROLIDINE RING TO RENDER RESISTANT TO BETA-LACTAMASES | MERCK & CO., INC. | 2001-10-02 | — | — | US | disclosed |
| US-6248916-B1 | WATER SOLUBLE, STRAIGHT CHAIN BORON-RICH OLIGOPHOSPHATE WHICH COMPRISES AN ORDERED PLURALITY OF CARBORANE MONOMER UNITS HAVING TWO HYDROXYL GROUPS ATTACHED THERETO BEING LINKED BY THE HYDROXYL GROUPS TO PHOSPHATE UNITS | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-06-19 | — | — | US | disclosed |
| EP-0937079-A4 | STABILIZED CARBAPENEM ANTIBIOTIC COMPOSITIONS AND METHOD OF MAKING | MERCK & CO INC (US) | 2001-01-24 | — | — | EP | disclosed |
| WO-2000066555-A1 | THIO-OXINDOLE DERIVATIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-11-09 | — | — | WO | disclosed |
| WO-2000008026-A2 | FUNGICIDAL FUSED BICYCLIC HETEROCYCLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-02-17 | — | — | WO | disclosed |
| EP-0937079-A1 | STABILIZED CARBAPENEM ANTIBIOTIC COMPOSITIONS AND METHOD OF MAKING | Merck & Co., Inc. (a New Jersey corp.) (US) | 1999-08-25 | — | — | EP | disclosed |
| US-5856551-A | REACTING DIHYDROXYCARBORANE WITH PHOSPHORUS COUPLING AGENT;THEN ALCOHOL | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-01-05 | — | — | US | disclosed |
| WO-1998018800-A1 | STABILIZED CARBAPENEM ANTIBIOTIC COMPOSITIONS AND METHOD OF MAKING | MERCK & CO., INC. (US) | 1998-05-07 | — | — | WO | disclosed |
| EP-0514917-B1 | Process for and 2-(cyanoimino)-quinazoline derivatives useful as intermediates in the preparation of 6,7-di-(chloro)-1,5-di(hydro)-imidazo-[2,1-b]quinazolin-2[3H]-one and process for preparing the 2-(cyanoimino)-quinazoline derivatives | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 1996-12-27 | — | — | EP | disclosed |
| WO-1995026359-A1 | MACROMOLECULAR STRUCTURES FOR BORON NEUTRON-CAPTURE THERAPY | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-10-05 | — | — | WO | disclosed |
| US-5426244-A | Para-selective; reacting a phenol with hydrogen peroxide in presence of crystalline titanosilicate catalyst and cyclic ether | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1995-06-20 | — | — | US | disclosed |
| US-5391737-A | Process for the preparation of 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2[3H]-one | EGIS GYOGYSZERGYAR (HU) | 1995-02-21 | — | — | US | disclosed |
| EP-0420248-B1 | Absorbent structures | KIMBERLY CLARK CO (US) | 1994-03-09 | — | — | EP | disclosed |
| EP-0514917-A1 | Process for and 2-(cyanoimino)-quinazoline derivatives useful as intermediates in the preparation of 6,7-di-(chloro)-1,5-di(hydro)-imidazo-[2,1-b]quinazolin-2[3H]-one and process for preparing the 2-(cyanoimino)-quinazoline derivatives | EGIS GYOGYSZERGYAR (HU) | 1992-11-25 | — | — | EP | disclosed |
| EP-0258662-B1 | COLOR PHOTOGRAPHS AND METHOD FOR PREPARATION OF THE SAME | FUJI PHOTO FILM CO., LTD. (JP) | 1992-05-27 | — | — | EP | disclosed |
| US-5082723-A | Diapers, sanitayr napkins | KIMBERLY-CLARK CORPORATION (US) | 1992-01-21 | — | — | US | disclosed |
| EP-0420248-A1 | Absorbent structures | KIMBERLY-CLARK CORPORATION (US) | 1991-04-03 | — | — | EP | disclosed |
| US-4976891-A | Antithrombotic, antivasoconstricting, antibronchoconstricting | SHIONOGI & CO., LTD. (JP) | 1990-12-11 | — | — | US | disclosed |
| US-4960909-A | ANTICOAGULANTS; VASODILATORS; BRONCHODILATOR AGENTS | SHIONOGI & CO., LTD. (JP) | 1990-10-02 | — | — | US | disclosed |
| EP-0221996-B1 | SUBSTITUTED 2,3-DIHYDRO-6-HYDROXY-PYRIMIDO [2,1-f] PURINE-4,8(1H,9H)-DIONES | SCHERING CORPORATION (US) | 1990-08-29 | — | — | EP | disclosed |
| CN-1008737-B | Process for preparing benzo [1] oxy [5] thiacycloheptene derivatives | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1990-07-11 | — | — | CN | disclosed |
| US-4920152-A | Crosslinking adsorbed coating with hydrophobic reagent | PURDUE RESEARCH FOUNDATION (US) | 1990-04-24 | — | — | US | disclosed |
| EP-0335390-A2 | Novel cephalosporin compounds | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1989-10-04 | — | — | EP | disclosed |
| EP-0258662-A2 | Color photographs and method for preparation of the same | FUJI PHOTO FILM CO., LTD. (JP) | 1988-03-09 | — | — | EP | disclosed |
| EP-0221996-A1 | SUBSTITUTED 2,3-DIHYDRO-6-HYDROXY-PYRIMIDO [2,1-f] PURINE-4,8(1H,9H)-DIONES. | SCHERING CORP (US) | 1987-05-20 | — | — | EP | disclosed |
| WO-1986006724-A1 | SUBSTITUTED 2,3-DIHYDRO-6-HYDROXY-PYRIMIDO AD2,1-f BD-PURINE-4,8(1H,9H)-DIONES | SCHERING CORPORATION (US) | 1986-11-20 | — | — | WO | disclosed |
| US-4435533-A | FIREPROOFING; WRINKLE RESISTANCE | TSOLIS ALEXANDROS K | 1984-03-06 | — | — | US | disclosed |
| US-4216206-A | Antibiotics S 53210/A-I, S 53210/A-II and S 53210/A-III | SANDOZ LTD. (CH) | 1980-08-05 | — | — | US | disclosed |
| EP-0008442-A2 | 2-Lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-03-05 | — | — | EP | disclosed |
| EP-0008442-A2 | 2-Lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-03-05 | — | — | EP | disclosed |